Histologic and immunohistochemical decision-making in endometrial adenocarcinoma
Open Access
- 1 August 2008
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 21 (8) , 937-942
- https://doi.org/10.1038/modpathol.2008.97
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Serous Endometrial Cancers That Mimic Endometrioid AdenocarcinomasThe American Journal of Surgical Pathology, 2004
- Uterine serous and grade 3 endometrioid carcinomasCancer, 2004
- Endometrial Glandular Dysplasia: A Newly Defined Precursor Lesion of Uterine Papillary Serous Carcinoma. Part I: Morphologic FeaturesInternational Journal of Surgical Pathology, 2004
- Interpretation of p53 Immunoreactivity in Endometrial Carcinoma: Establishing a Clinically Relevant Cut-Off LevelInternational Journal of Gynecological Pathology, 2004
- P53 overexpression predicts endometrial carcinoma recurrence better than HER-2/neu overexpressionEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2001
- Altered PTEN Expression as a Diagnostic Marker for the Earliest Endometrial PrecancersJNCI Journal of the National Cancer Institute, 2000
- Minimal Uterine Serous CarcinomaThe American Journal of Surgical Pathology, 2000
- p53 in endometrial cancer and its putative precursors: Evidence for diverse pathways of tumorigenesisHuman Pathology, 1995
- Endometrial intraepithelial carcinoma: A distinctive lesion specifically associated with tumors displaying serous differentiationHuman Pathology, 1995
- Uterine papillary serous carcinomaThe American Journal of Surgical Pathology, 1982